PLoS By Category | Recent PLoS Articles

Biochemistry - Molecular Biology - Oncology - Urology


LncRNAs Expression Signatures of Renal Clear Cell Carcinoma Revealed by Microarray
Published: Monday, August 06, 2012
Author: Gan Yu et al.

by Gan Yu, Weimin Yao, Ji Wang, Xin Ma, Wei Xiao, Heng Li, Ding Xia, Yang Yang, Kangli Deng, Haibing Xiao, Bohan Wang, Xiaolin Guo, Wei Guan, Zhiquan Hu, Yinqi Bai, Hua Xu, Jihong Liu, Xu Zhang, Zhangqun Ye

Background

Long noncoding RNAs (lncRNAs) are an important class of pervasive genes involved in a variety of biological functions. They are aberrantly expressed in many types of cancers. In this study, we described lncRNAs profiles in 6 pairs of human renal clear cell carcinoma (RCCC) and the corresponding adjacent nontumorous tissues (NT) by microarray.

Methodology/Principal Findings

With abundant and varied probes accounting 33,045 LncRNAs in our microarray, the number of lncRNAs that expressed at a certain level could be detected is 17157. From the data we found there were thousands of lncRNAs that differentially expressed (=2 fold-change) in RCCC tissues compared with NT and 916 lncRNAs differentially expressed in five or more of six RCCC samples. Compared with NT, many lncRNAs were significantly up-regulated or down-regulated in RCCC. Our data showed that down-regulated lncRNAs were more common than up-regulated ones. ENST00000456816, X91348, BC029135, NR_024418 were evaluated by qPCR in sixty-three pairs of RCCC and NT samples. The four lncRNAs were aberrantly expressed in RCCC compared with matched histologically normal renal tissues.

Conclusions/Significance

Our study is the first one to determine genome-wide lncRNAs expression patterns in RCCC by microarray. The results displayed that clusters of lncRNAs were aberrantly expressed in RCCC compared with NT samples, which revealed that lncRNAs differentially expressed in tumor tissues and normal tissues may exert a partial or key role in tumor development. Taken together, this study may provide potential targets for future treatment of RCCC and novel insights into cancer biology.

  More...

 
//-->